News | Radiation Therapy | September 26, 2016

Integrated technology solution enables clinicians to address highly-complex SRS and SBRT treatments with increased confidence

Elekta, ASTRO 2016, HD Dynamic Radiosurgery, brachytherapy

September 26, 2016 — At the American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 25-28 in Boston, Elekta will showcase its HD Dynamic Radiosurgery that leverages the core strengths of Versa HD linear accelerator and Monaco treatment planning system.

Versa HD combines High Definition Dynamic Radiosurgery treatment capabilities and precision radiotherapy in a single platform. Equipped with sophisticated full-field, high-definition beam-shaping technology and High Dose Rate mode, Versa HD offers the precision and speed necessary to deliver versatile stereotactic treatments throughout the body. Monaco powers more efficient high-definition planning with true Monte Carlo accuracy and advanced multi-criterial optimization.

The combination of Versa HD and Monaco enables more modulation in a single arc with 1,024 dynamic control points enabling delivery of highly-conformal stereotactic radiosurgery and stereotactic body radiotherapy treatments within standard treatment slots, irrespective of complexity or anatomy.

Visitors to Elekta’s will also have an opportunity to learn more about:

  • Mosaiq Oncology Analytics, a knowledge management solution that unlocks data into actionable information to enable continuous improvement of clinical, operational and financial performance;
  • Leksell Gamma Knife Icon, the latest technological advance in Elekta’s Gamma Knife radiosurgery platform, enables precision cranial radiosurgery with online dose adaptation. Featuring sophisticated imaging and motion management technologies, Icon is making cranial radiosurgery available to more patients by offering frameless fractionated treatments with similar accuracy as frame-based single-session radiosurgery; 
  • Venezia, the company’s new gynecological applicator provides a new option for treating advanced-stage cervical cancer. Designed to support the recommendations for 3-D image-guided adaptive brachytherapy for locally advanced cervical cancer, Venezia allows clinicians to treat IIIA and IIIB tumors in the cervix, parametrium and vaginal extensions through a combination of straight and oblique needles with consistent and reproducible needle placement. (Venezia is not available for sale or distribution in all markets, is not for sale in the United States and is pending U.S. Food and Drug Administration (FDA) 510(k) clearance; and
  • Advanced imaging and motion management solutions, which allow more focused guidance for precise dose targeting and critical structure avoidance. XVI 4-D reduces margins with online automated motion guidance and increases precision through critical structure avoidance. Clarity Autoscan delivers precise intra-fraction motion management for prostate featuring continuous soft-tissue imaging.

For more information: www.elekta.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now